Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

87.74
Delayed Data
As of Jul 01
 +1.72 / +2.00%
Today’s Change
75.90
Today|||52-Week Range
143.45
-30.27%
Year-to-Date
Zacks.com featured highlights: Antero Resources, ZELTIQ Aesthetics, Vertex Pharmaceut...
Jun 28 / Zacks.com - Paid Partner Content
Dump These 5 Toxic Stocks to Avoid Portfolio Bleeding
Jun 27 / Zacks.com - Paid Partner Content
How Does Brexit Impact Healthcare Stocks?
Jun 27 / Zacks.com - Paid Partner Content
3 Biotech Stocks to Buy in the Wake of the Brexit Vote
Jun 24 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close86.02
Today’s open85.67
Day’s range85.17 - 88.46
Volume1,292,792
Average volume (3 months)1,949,743
Market cap$21.3B
Dividend yield--
Data as of 4:00pm ET, 07/01/2016

Growth & Valuation

Earnings growth (last year)+26.43%
Earnings growth (this year)+198.65%
Earnings growth (next 5 years)+43.00%
Revenue growth (last year)+77.86%
P/E ratioNM
Price/Sales29.41
Price/Book22.54

Competitors

 Today’s
change
Today’s
% change
MYLMylan NV+0.24+0.56%
ZTSZoetis Inc-0.01-0.02%
ALXNAlexion Pharmaceutic...+1.83+1.57%
INCYIncyte Corp+1.29+1.61%
Data as of 4:01pm ET, 07/01/2016

Financials

Next reporting dateJuly 25, 2016
EPS forecast (this quarter)$0.23
Annual revenue (last year)$1.0B
Annual profit (last year)-$556.3M
Net profit margin-53.89%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeffrey M. Leiden
SVP &
GM-International Commercial Operations
Simon Bedson
Corporate headquarters
Boston, Massachusetts

Forecasts

Partner Offers

Search for Jobs